Physician

Rachel C Ness, M.D.

According to 2025 Medicare claims, Rachel Ness, M.D. (NPI: 1205031713) practices dermatology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is RACHEL NESS M.D., PLLC (NPI: 1699942581; TIN: 300476402) and primary practice location at 58104-4564.

Ness' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 422 traditional Medicare patients, billed 6,682 HCPCS/CPT codes, and received $724,189 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 423 prescription claims across 197 beneficiaries totaling $149,991 in drug costs, led by Betamethasone Dipropionate (Betamethasone Dipropionate). Open Payments data shows 34 records totaling $874. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $73,167 to $724,189. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $69,472 to $149,991. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$362K$724K2015 Medicare payment: $73,167 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $60,449 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $102,136 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $145,160 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $235,089 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $277,631 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $282,256 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $536,718 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $648,894 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $724,189 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152131,363$73,167
20161951,333$60,449
20172942,216$102,136
20183742,767$145,160
20195393,879$235,089
20205844,522$277,631
20216324,412$282,256
20225055,754$536,718
20234226,337$648,894
20244226,682$724,189

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$144K$287K2015 Drug cost: $69,472 (USD; Tot_Drug_Cst)2016 Drug cost: $92,037 (USD; Tot_Drug_Cst)2017 Drug cost: $89,360 (USD; Tot_Drug_Cst)2018 Drug cost: $122,230 (USD; Tot_Drug_Cst)2019 Drug cost: $249,366 (USD; Tot_Drug_Cst)2020 Drug cost: $287,103 (USD; Tot_Drug_Cst)2021 Drug cost: $233,805 (USD; Tot_Drug_Cst)2022 Drug cost: $167,259 (USD; Tot_Drug_Cst)2023 Drug cost: $155,524 (USD; Tot_Drug_Cst)2024 Drug cost: $149,991 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201595284$69,472
201691273$92,037
2017111279$89,360
2018134342$122,230
2019143360$249,366
2020165472$287,103
2021149453$233,805
2022159418$167,259
2023165410$155,524
2024197423$149,991

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more97158$91
17110Destruction of skin growth, 1-14 growths154201$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more239416$67
17000Destruction of precancer skin growth, 1 growth154199$33
17003Destruction of precancer skin growth, 2-14 growths97553$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Betamethasone DipropionateBetamethasone Dipropionate591,681$2,080
TacrolimusTacrolimus18505$1,439
KetoconazoleKetoconazole652,020$1,371
Clobetasol PropionateClobetasol Propionate16450$983
Doxycycline HyclateDoxycycline Hyclate251,035$539

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$874REVANCE THERAPEUTICS, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rachel C. Ness, M.D.?

Tedicare shows public-source Medicare data for Rachel C. Ness, M.D. (NPI 1205031713), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rachel C. Ness, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rachel C. Ness, M.D.?

Rachel C. Ness, M.D. is linked to RACHEL NESS M.D., PLLC (billing NPI 1699942581) in the available physician profile data.

Does Rachel C. Ness, M.D. have Open Payments data?

Rachel C. Ness, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.